Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Accurate protein modeling can help develop new treatments for prostate cancer and other diseases.

Tripterygium wilfordii multiglycoside effectively reduced prostate enlargement in rats without harmful effects.

Early hair loss may indicate future prostate issues.

Higher urethral PSA levels after prostate removal may be linked to more scalp hair loss and more PSA in urethral glands.

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

Higher free testosterone levels can increase bone density and decrease body fat but may raise the risk of prostate cancer, hair loss, and benign prostate enlargement.

Leonuri Herba alkaloids may help treat hormone-induced enlarged prostate in rats.